Holen Sie sich die Stockscreener-App
1.6986
7.61%
-0.1414
Finanzdaten der Gain Therapeutics Inc-Aktie (GANX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | -0.3052 | 0.1054 | 0.0845 |
Operating Expenses
|
16.48%
5.0895
|
4.3694 | 3.3311 | 4.459 | 8.1828 |
| Operating Income/Loss |
16.48%
-5.0895
|
-4.3694 | -3.3311 | -4.459 | -8.1828 |
| Income/Loss From Continuing Operations Before Tax |
27.96%
-5.6679
|
-4.4295 | -3.2635 | -4.4747 | -8.1419 |
| Income Tax Expense/Benefit |
40.49%
0.1412
|
0.1005 | 0.5047 | 0.011 | 0.00121 |
| Income/Loss From Continuing Operations After Tax |
28.23%
-5.8091
|
-4.5301 | -3.7682 | -4.4857 | -8.1431 |
|
Net Income/Loss
|
28.23%
-5.8091
|
-4.5301 | -3.7682 | -4.4857 | -8.1431 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5.77%
30.34
|
28.69 | 1.608 | 26.53 | 19.22 |
| Diluted Average Shares |
5.77%
30.34
|
28.69 | 1.608 | 26.53 | 19.22 |
| Basic Earnings Per Share |
18.75%
-0.19
|
-0.16 | -0.11 | -0.17 | -0.42 |
| Diluted Earnings Per Share |
18.75%
-0.19
|
-0.16 | -0.11 | -0.17 | -0.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.24%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):